
The NHS is to roll out a life-extending drug to patients with a rare form of throat and stomach cancer.
The National Institute for Health and Care Excellence (NICE) approved the use of Nivolumab – used to treat rare forms of gastroesophageal cancer - which will see around 3000 people eligible in the UK.